Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lajer, Panna"'
Autor:
Szilvásy, Nóra1 (AUTHOR) nora.szilvasy@crl.com, Lajer, Panna1 (AUTHOR) panna.lajer@gmail.com, Horváth, Attila2 (AUTHOR) sztewee@gmail.com, Veres, Katalin2 (AUTHOR) veres.katalin@szte.hu, Hohmann, Judit2,3 (AUTHOR) hohmann.judit@szte.hu, Schelz, Zsuzsanna4 (AUTHOR) schelz.zsuzsanna@szte.hu, Minorics, Renáta4 (AUTHOR) kanizsaine.minorics.renata@szte.hu, Zupkó, István4 (AUTHOR) zupko.istvan@szte.hu, Gáborik, Zsuzsanna1 (AUTHOR) zsuzsanna.gaborik@crl.com, Kis, Emese1 (AUTHOR) emese.kis@crl.com, Temesszentandrási-Ambrus, Csilla1 (AUTHOR) csilla.temesszentandrasi-ambrus@crl.com
Publikováno v:
Pharmaceutics. Nov2024, Vol. 16 Issue 11, p1363. 19p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nichetti F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Silvestri M; Department of Diagnostic Innovation, Second Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Agnelli L; Department of Diagnostic Innovation, Second Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Franza A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Pircher C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Rota S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Ambrosini P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Hüllein J; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Randon G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Lajer P; Division of Translational Medical Oncology, Section of Translational Cancer Epigenomics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Perrone F; Department of Diagnostic Innovation, Second Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tamborini E; Department of Diagnostic Innovation, Second Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Leoncini G; Department of Pathology and Laboratory Medicine, First Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Coppa J; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Busset MDD; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pusceddu S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Milione M; Department of Pathology and Laboratory Medicine, First Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Morano F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Pruneri G; Department of Diagnostic Innovation, Second Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Mazzaferro V; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Lipka DB; Division of Translational Medical Oncology, Section of Translational Cancer Epigenomics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Köhler BC; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Liver Cancer Center Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Hübschmann D; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany., Fröhling S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Dec; Vol. 13 (23), pp. e70393.